Skip to main content

FemInnovation Launches to Revolutionize Women's Health with Innovation and Advocacy

Founder Bethany Corbin leads the charge in driving transformative change for women's health through tailored programs, education, and empowerment.

CHARLOTTE, NC / ACCESSWIRE / June 8, 2023 / FemInnovation, led by founder and CEO Bethany Corbin, a renowned health innovation and femtech attorney, has launched with a mission to drive innovation, enhance access, and revolutionize modern healthcare for women worldwide. The company offers tailored legal and educational programs, thought leadership, and advocacy to empower founders, clinicians, politicians, advocates, and supporters in transforming and disrupting traditional care delivery for women's health.

FemInnovation envisions a world where women's health is recognized as human health, driven by data-backed evidence and research specific to diseases impacting individuals identifying as female. The company aims to promote sustained growth and investment in women's health and the femtech industry, enabling women to reclaim their health narratives and advocate for their well-being.

Bethany Corbin, founder and CEO of FemInnovation, stated, "Following the overturn of Roe v. Wade, we are at a crucial juncture for women's health. Now more than ever, societal acceptance of women's health and the development of innovative solutions are required to enhance health equity and ensure access to care. FemInnovation is designed to help drive these important and meaningful objectives by supporting and bridging gaps between founders, clinicians, politicians, investors, and the general public. Only by addressing the barriers to women's health at each of these levels can we hope to inspire true and lasting change."

The first phase of FemInnovation, launched on June 1, 2023, provides legal and strategic business advice to women's health founders. The company offers live, virtual courses for early-stage and international women's health companies, delivering comprehensive legal strategies for the U.S. market. The courses feature actionable takeaways, legal overviews, insights, and networking opportunities with like-minded founders. The first cohort begins on June 12th, with additional cohorts planned.

FemInnovation also introduces clinician education to involve more healthcare professionals in the femtech industry. The company bridges the gap between femtech founders and clinicians by offering educational lectures, presentations, corporate trainings, and seminars. Additionally, FemInnovation aims to change the women's health narrative globally by breaking down stigmas and facilitating open conversations. The company welcomes invitations from organizations and institutions, including universities, to present on women's health empowerment, advocacy, and femtech.

As part of its first phase launch, FemInnovation debuts the "FemInnovation" podcast, hosted by Bethany Corbin. The podcast addresses critical issues impacting women's health, providing legal, practical, and ethical insights to women's health founders and supporters. The podcast features guest speakers discussing challenges, changemakers, the future of femtech, and navigating the lifecycle of a women's health startup. The podcast is available on major podcast channels and the FemInnovation website.

FemInnovation's uniqueness lies in its commitment to enhancing women's health innovation on four levels: entrepreneurship, clinical, political, and societal. The company promotes collaboration and partnerships across the women's health industry, serving as a comprehensive platform for founders, clinicians, investors, and advocates. The courses provided by FemInnovation offer crucial legal insights for early-stage founders who are often underserved.

"We are dedicated to driving meaningful and actionable change in women's health," added Bethany Corbin. "By addressing the societal, political, clinical, and entrepreneurial barriers that have long plagued the industry, FemInnovation strives to inspire true and lasting transformation."

Looking ahead, FemInnovation is actively preparing for its Phase II launch, scheduled for later this year. Phase II will introduce a comprehensive platform for founders, clinicians, investors, and healthcare advocates. The platform will offer resources, coaching services, networking opportunities, and educational content based on FemInnovation's four pillars. The company is seeking strategic partnerships to build the platform's content and welcomes contributions from interested parties.

For more information on FemInnovation, please visit https://www.feminnovation.com. FemInnovation can also be found on LinkedIn and Instagram.

###

About the Founder:
Bethany Corbin, Founder & CEO of FemInnovation, is a recognized thought leader at the intersection of women's health, law, and technology. As an experienced women's health innovation attorney, Bethany helps founders, clinicians, politicians, and advocates transform and disrupt "standard" care delivery for women's health. Bethany has been named a Top 200 Trailblazing Leader in Women's Health and Femtech (Women of Wearables) and is a recipient of the 2023 Champion in Healthcare Award (Global HEaL Conference). Her strategic insights have been featured in top news outlets, including Forbes, Fortune, BBC, NPR, Buzzfeed, The Atlantic, VICE, Cosmopolitan, Teen Vogue, and more. Bethany has testified about the importance of data privacy for reproductive health before the Maryland Cybersecurity Council's Ad Hoc Committee on Consumer Privacy and is an Advisory Board Member for Kisaco Research's Women's Health Innovation conference series. She is also a contributor to Entrepreneur, MedCity News, and Med Device Online.

Evan Sneider
Red Rooster PR
esneider@redroosterpr.com
954-673-6835

SOURCE: FemInnovation



View source version on accesswire.com:
https://www.accesswire.com/760164/FemInnovation-Launches-to-Revolutionize-Womens-Health-with-Innovation-and-Advocacy

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.